» Articles » PMID: 28132394

IL-5 Blocks Apoptosis and Tau Hyperphosphorylation Induced by Aβ Peptide in PC12 Cells

Overview
Specialties Biochemistry
Physiology
Date 2017 Jan 30
PMID 28132394
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The primary features of Alzheimer's disease (AD) are extracellular amyloid plaques consisting mainly of deposits of amyloid β (Aβ) peptides and intracellular neurofibrillary tangles (NFTs). Sets of evidence suggest that interleukin-5 (IL-5) is involved in the pathogenesis of AD. Herein, we investigated the protective role of IL-5 in PC12 cells, to provide new insights into understanding this disease. Western blot was employed to assess the protein levels of Bax and phospho-tau as well as phospho-JAK2; MTT assay was performed to decipher cell viability. Treatment of IL-5 decreased Aβ-induced tau phosphorylation and apoptosis, effects blunted by JAK2 inhibition. IL-5 prevents Aβ-evoked tau protein hyperphosphorylation and apoptosis through JAK2 signaling.

Citing Articles

Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning.

Safi A, Giunti E, Melikechi O, Xia W, Melikechi N Heliyon. 2025; 11(3):e42349.

PMID: 39981365 PMC: 11840181. DOI: 10.1016/j.heliyon.2025.e42349.


A Potential Role of Interleukin-5 in the Pathogenesis and Progression of Amyotrophic Lateral Sclerosis: A New Molecular Perspective.

Motataianu A, Andone S, Stoian A, Balasa R, Hutanu A, Sarmasan E Int J Mol Sci. 2024; 25(7).

PMID: 38612591 PMC: 11011909. DOI: 10.3390/ijms25073782.


Qi-fu-yin attenuated cognitive disorders in 5xFAD mice of Alzheimer's disease animal model by regulating immunity.

Yang X, Ye T, He Y, Wen L, Cheng X Front Neurol. 2023; 14:1183764.

PMID: 37441611 PMC: 10333586. DOI: 10.3389/fneur.2023.1183764.


FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.

Lui A, Vanleuven J, Perekopskiy D, Liu D, Xu D, Alzayat O Pharmaceuticals (Basel). 2022; 15(12).

PMID: 36558997 PMC: 9784968. DOI: 10.3390/ph15121546.


Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia.

Hoyer-Kimura C, Konhilas J, Mansour H, Polt R, Doyle K, Billheimer D J Neuroinflammation. 2021; 18(1):236.

PMID: 34654436 PMC: 8520282. DOI: 10.1186/s12974-021-02281-1.


References
1.
Darvin P, Joung Y, Yang Y . JAK2-STAT5B pathway and osteoblast differentiation. JAKSTAT. 2014; 2(4):e24931. PMC: 3894232. DOI: 10.4161/jkst.24931. View

2.
Sheikh A, Nagai A, Wakabayashi K, Narantuya D, Kobayashi S, Yamaguchi S . Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5. Neurobiol Dis. 2010; 41(3):717-24. DOI: 10.1016/j.nbd.2010.12.009. View

3.
Zambrano A, Otth C, Mujica L, Concha I, Maccioni R . Interleukin-3 prevents neuronal death induced by amyloid peptide. BMC Neurosci. 2007; 8:82. PMC: 2089076. DOI: 10.1186/1471-2202-8-82. View

4.
Lins C, Borojevic R . Interleukin-5 receptor alpha chain expression and splicing during brain development in mice. Growth Factors. 2002; 19(3):145-52. DOI: 10.3109/08977190109001082. View

5.
Quelle F, Sato N, Witthuhn B, Inhorn R, Eder M, Miyajima A . JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol. 1994; 14(7):4335-41. PMC: 358804. DOI: 10.1128/mcb.14.7.4335-4341.1994. View